BioCentury
ARTICLE | Finance

Lightstone's first

Lightstone Ventures makes first investment in NCE conjugate play Catabasis

November 18, 2013 8:00 AM UTC

Lightstone Ventures led Catabasis Pharmaceuticals Inc.'s $32.4 million series B round last week, marking the healthcare VC's first investment.

An undisclosed public crossover fund also joined all current investors in the round: SV Life Sciences, Clarus Ventures, MedImmune Ventures and Advanced Technology Ventures (ATV)...